Fresenius Delivers First US Biosimilar Approval

Kabi Receives Long-Awaited Nod From FDA For Stimufend Version Of Pegfilgrastim

US flag thumbs up
Fresenius Kabi has its first US biosimilar approval • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Biosimilars

More from Products